￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Medical drugs

Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What are the precautions when taking Revumenib?

2026-02-01 22:25:32

Check Details
Which drugs may Zenocutuzumab conflict with?

2026-02-01 22:25:32

Check Details
Does Cosibelimab belong to the PD-L1 immunosuppressant category?

2026-02-01 22:25:32

Check Details
What is the average survival time of patients after taking Ensartinib?

2026-02-01 22:25:32

Check Details
Can Datopotamab be used with other drugs?

2026-02-01 22:25:32

Check Details
Is the disease prone to relapse after discontinuation of Mirdametinib?

2026-02-01 22:25:32

Check Details
What type of patient population is Vimseltinib mainly suitable for?

2026-02-01 22:25:32

Check Details
What special precautions should be taken while taking Atrasentan?

2026-02-01 22:25:32

Check Details
Telisotuzumab medical insurance reimbursement policy and specific details

2026-02-01 22:25:32

Check Details
Is the combination of Inavolisib and Fulvestrant more effective?

2026-02-01 22:25:32

Check Details
Nilotinib (Nilotinib) domestic launch time and access methods

2026-02-01 22:25:32

Check Details
Recommended daily dosage and treatment regimen of Revumenib

2026-02-01 22:25:32

Check Details
Category
相关知识